AbbVie News

UBS Maintains AbbVie(ABBV.US) With Hold Rating, Cuts Target Price to $181

Futu News03:32

AbbVie Is Maintained at Buy by Citigroup

Dow Jones03:08

BMO Capital Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $208

Futu NewsNov 12 22:35

AbbVie Is Maintained at Overweight by Morgan Stanley

Dow JonesNov 12 21:39

AbbVie Analyst Ratings

BenzingaNov 12 21:31

Morgan Stanley Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $224

Futu NewsNov 12 19:35

Citi Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $215

Futu NewsNov 12 19:35

AbbVie Buy Rating Affirmed Despite Emraclidine Setback, Driven by Skyrizi and Rinvoq Growth

TipRanksNov 12 19:13

Positive Outlook on AbbVie: Geoff Meacham's Buy Rating and Potential of Emraclidine Amid Schizophrenia Trial Challenges

TipRanksNov 12 19:12

BMO Capital Adjusts Price Target on AbbVie to $208 From $228, Maintains Outperform Rating

MT NewswiresNov 12 18:46

Citigroup Adjusts AbbVie Price Target to $215 From $226

MT NewswiresNov 11 23:51

Barclays Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $212

Futu NewsNov 11 23:33

Positive Long-Term Growth Outlook for AbbVie Despite Emraclidine Setback: Analyst Maintains Buy Rating

TipRanksNov 11 23:19

AbbVie Analyst Ratings

BenzingaNov 7 02:07

Guggenheim Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $221

Futu NewsNov 6 21:38

Morgan Stanley Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $231

Futu NewsNov 6 20:34

Truist Financial Maintains AbbVie(ABBV.US) With Buy Rating

Futu NewsNov 6 20:34

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), NeoGenomics (NEO) and Ultragenyx Pharmaceutical (RARE)

TipRanksNov 6 20:08

Deutsche Bank Adjusts AbbVie Price Target to $180 From $175, Maintains Hold Rating

MT NewswiresNov 5 20:45

AbbVie Analyst Ratings

BenzingaNov 5 00:29